Jasmin Bartl

发表

Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease.

Isidro Ferrer, Andreas J Fallgatter, Jürgen Deckert, 2014, Journal of Alzheimer's disease : JAD.

Three-dimensional analyses of vascular network morphology in a murine lymph node by X-ray phase-contrast tomography with a 2D Talbot array

C. Lohr, M. Busse, J. Herzen, 2022, Frontiers in Immunology.

Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.

Emmanuel Barillot, Arnau Montagud, Loredana Martignetti, 2018, Cancer cell.

The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma

M. Wolter, G. Reifenberger, M. Weller, 2021, Cell Death & Disease.

Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors

G. Reifenberger, M. Kool, S. Pfister, 2022, Cell Death & Disease.

Methylphenidate enhances neuronal differentiation and reduces proliferation concomitant to activation of Wnt signal transduction pathways

S. Walitza, E. Grünblatt, J. Bartl, 2018, Translational Psychiatry.

Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease.

P Riederer, P. Riederer, R. Ravid, 2007, Journal of Alzheimer's disease : JAD.

Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene

P. Riederer, E. Grünblatt, P. Fischer, 2011, BMC Medical Genetics.

Enhancement of cell viability after treatment with polyunsaturated fatty acids

S. Walitza, E. Grünblatt, J. Bartl, 2014, Neuroscience Letters.

The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors

Alexander K. Buell, M. Wolter, G. Reifenberger, 2022, Nature Communications.

Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation

G. Reifenberger, S. Keir, D. Bigner, 2023, Journal for ImmunoTherapy of Cancer.

Further evidence for plasma progranulin as a biomarker in bipolar disorder.

S. Kittel-Schneider, A. Reif, J. Volkert, 2014, Journal of affective disorders.

In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder

S. Walitza, Z. Marinova, E. Grünblatt, 2012, Journal of Neural Transmission.

Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma

G. Reifenberger, A. Pandyra, M. Remke, 2023, Acta Neuropathologica.

Pilot study: potential transcription markers for adult attention-deficit hyperactivity disorder in whole blood

K. Lesch, P. Riederer, S. Walitza, 2012, ADHD Attention Deficit and Hyperactivity Disorders.

Methyl- and acetyltransferases are stable epigenetic markers postmortem

P. Falkai, P. Riederer, T. Michel, 2011, Cell and Tissue Banking.

Gene expression as peripheral biomarkers for sporadic Alzheimer's disease.

Sonja Zehetmayer, Peter Riederer, P. Riederer, 2009, Journal of Alzheimer's disease : JAD.

Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease.

I. Ferrer, A. Fallgatter, H. Heinsen, 2013, Current Alzheimer research.

Diabetes Type II: A Risk Factor for Depression–Parkinson–Alzheimer?

P. Riederer, E. Grünblatt, G. Laux, 2011, Neurotoxicity Research.

Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease.

P. Riederer, R. Ravid, M. Gerlach, 2007, Journal of Alzheimer's disease : JAD.

The link between iron, metabolic syndrome, and Alzheimer’s disease

P. Riederer, E. Grünblatt, J. Bartl, 2011, Journal of Neural Transmission.

The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro

M. Parrinello, P. Riederer, S. Walitza, 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study.

Sonja Zehetmayer, Peter Riederer, P. Riederer, 2009, Journal of psychiatric research.

Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity

P. Riederer, M. Gerlach, E. Grünblatt, 2014, Journal of Neural Transmission.

Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways

Peter Riederer, P. Riederer, E. Grünblatt, 2012, Journal of Neural Transmission.

The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro

M. Parrinello, P. Riederer, S. Walitza, 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Alzheimer's disease and type 2 diabetes: Two diseases, one common link?

P. Riederer, E. Grünblatt, C. Monoranu, 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction

P. Riederer, S. Walitza, E. Grünblatt, 2015, Journal of molecular psychiatry.

Methylphenidate enhances neural stem cell differentiation

P. Riederer, E. Grünblatt, Hiroki Ozawa, 2013, Journal of molecular psychiatry.

Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease.

I. Ferrer, A. Fallgatter, H. Heinsen, 2014, Journal of Alzheimer's disease : JAD.

Effects of methylphenidate: the cellular point of view

P. Riederer, S. Walitza, M. Gerlach, 2010, Attention deficit and hyperactivity disorders.